CVS Health is exploring options that could include a breakup of the company to separate its retail and insurance units ...

Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...

Metsera, a biotech focused on obesity treatments, came out of stealth only this year, and its lead drug is still in early ...

Micky Tripathi, the top AI official at HHS, faces down an enormous task with a dearth of people, resources, and enforcement ...

Marrazzo became the first new director of the National Institute of Allergy and Infectious Diseases in decades, taking over a ...

Sen. Bill Cassidy, seeking ways to help lower drug prices, is pushing the FDA to provide more clarity on patent listings in a ...

The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

Five ways reforming the ad comms process can help the FDA to continue making the best evidence-based decisions and ensure the ...

A large outbreak of Marburg virus in Rwanda is drawing international concern about the possibility of spread beyond the ...

The move came after the U.S. Health and Resources Administration last week threatened the health care giant with sanctions if ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...